Communiqués Cresco Labs Inc.

Actions

CL

CA22587M1068

Produits pharmaceutiques

Temps Différé Canadian Securities Exchange 20:45:17 30/09/2026			Varia. 5j.	Varia. 1 janv.
0,9500 ^CAD	-7,77%		-13,64%	-42,77%

17/09	Cresco Labs Inc. annonce la nomination d'Edward Tilly en tant qu'administrateur indépendant et membre du comité d'audit, à compter du 18 septembre 2026	CI
02/09	Cresco Labs Inc. (CSE:CL) a acquis PharmaCann Penn, LLC pour 50 millions de dollars.	CI

Communiqués

24/09	Cresco Labs Announces Filing of Management Information Circular for Annual General and Special Meeting	BU
17/09	Cresco Labs Appoints Edward Tilly to Board of Directors	BU
02/09	Cresco Labs Acquires Nine Pennsylvania Dispensaries in Accretive Transaction to Strengthen Market Leadership	BU
06/08	Cresco Labs : Second Quarter 2026 Financial Statement	PU
06/08	Cresco Labs Reports Second Quarter 2026 Financial Results; Delivers $173 Million in Revenue and $40 Million in Adjusted EBITDA	BU
13/07	Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026	BU
08/06	Cresco Labs Closes US$50 Million Revolving Credit Facility with Needham Bank	BU
27/05	Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration	BU
11/05	Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety	BU
08/05	Cresco Labs Reports First Quarter 2026 Financial Results, Advances Multiple Growth Initiatives	BU
05/05	Cresco Labs Opens Sunnyside Aberdeen, Marking Second Ohio Dispensary Opening in a Month	BU
23/04	Cresco Labs CEO: Rescheduling Ushers in a New Era of Care for Medical Cannabis Patients	BU
23/04	Cresco Labs to Report First Quarter 2026 Financial Results on May 8, 2026	BU
10/04	Cresco Labs Opens Sunnyside Bridgeport, Expanding Access in the Ohio Valley	BU
02/04	Cresco Labs Awarded Texas Medical Cannabis License	BU
06/03	Cresco Labs : Fourth Quarter 2025 Financial Statement	PU
06/03	Cresco Labs : Fourth Quarter 2025 MD&A	PU
05/03	Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement	BU
23/02	Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026	BU
09/01	Cresco Labs Opens Sunnyside Tamarac, Expanding Patient Access in Broward County, Florida	BU
18/12	Cresco Labs CEO: Rescheduling Marks Historic Shift for Cannabis Industry	BU
18/12	Canadian Investment Regulatory Organization Trade Resumption - CL	AQ
18/12	Canadian Investment Regulatory Organization Trading Halt - CL	AQ
12/11	Cresco Labs Launches Flagship Flower Brand in Germany	BU
11/11	Cresco Labs : Third Quarter 2025 Earnings Conference Call Transcript	PU